Press/Media
- 16 results
Search results
-
New Prostate Cancer Study Results from National Cancer Institute (NCI) Described (A selective CutMix approach improves generalizability of deep learning-based grading and risk assessment of prostate cancer)
Gyorgy Petrovics, Gregory Chesnut, Albert Dobi & Shyh-Han Tan
26/12/24
1 item of Media coverage
Press/Media
-
New Findings on Prostate Cancer Described by Investigators at Uniformed Services University of the Health Sciences (Germline Mutations and Ancestry In Prostate Cancer)
Gregory Chesnut, Albert Dobi, Binil Eldhose & Indu Kohaar
19/02/24
1 item of Media coverage
Press/Media
-
New Prostate Cancer Study Findings Have Been Reported from Uniformed Services University of the Health Sciences (Association of TP53 Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men)
Albert Dobi, Indu Kohaar & Gyorgy Petrovics
31/05/23
1 item of Media coverage
Press/Media
-
-
-
-BPGbio Announces Oncology Drug Pipeline and Prostate Cancer Biomarker Developments at AACR
13/04/23
2 items of Media coverage
Press/Media
-
BPGbio Announces Oncology Drug Pipeline and Prostate Cancer Biomarker Developments at AACR
11/04/23 → 12/04/23
12 items of Media coverage
Press/Media
-
-
-
US Patent Issued to The Henry M. Jackson Foundation for the Advancement of Military Medicine on Nov. 8 for "ERG monoclonal antibodies" (Maryland Inventors)
9/11/22
1 item of Media coverage
Press/Media
-
Australia: The Henry M. Jackson Foundation for the Advancement of Military Medicine Receives Patent for 'Azophenols as ERG oncogene inhibitors'
7/05/21
1 item of Media coverage
Press/Media
-
Australia Patent: Application for 'Genomic rearrangements associated with prostate cancer and methods of using the same' Lapses
Gyorgy Petrovics & Albert Dobi
23/04/21
1 item of Media coverage
Press/Media